Top 100 Contractors in NAICS 325413: In-Vitro Diagnostic Substance Manufacturing, FY2021

Parent companies by net contract obligations Oct 1, 2020 – Sep 30, 2021 Code page on GovTribe

The top 10 won 88% of FY2021 NAICS 325413 contract dollars

Ranking facts

Contract obligations
$2,011,819,451 Net of deobligations, by contracts coded NAICS 325413
Contractors
267 Parent companies with an obligation
Largest contractor
Abbott Laboratories $1.38 billion, 65.4% of obligations
Data as of

Contract actions from FPDS (SAM.gov). How the rankings work · Download all 100 rows as CSV

Full ranking

Rank Contractor Net obligations Share Trend
1 $1,380,472,329
Rank history: #2 in FY2022, #3 in FY2023, not on the FY2024 list and #4 in FY2025; up 2 since FY2020.
2 $157,682,712
Rank history: not on the FY2022–FY2025 lists; up 27 since FY2020.
3 $81,473,156
Rank history: #15 in FY2022, #20 in FY2023, #18 in FY2024 and #80 in FY2025; down 2 since FY2020.
4 $76,132,397
Rank history: #5 in FY2022, #11 in FY2023, #1 in FY2024 and #1 in FY2025; up 1 since FY2020.
5 $54,292,680
Rank history: #43 in FY2022, #71 in FY2023, #21 in FY2024 and #7 in FY2025; up 9 since FY2020.
6 $39,012,246
Rank history: #16 in FY2022 and not on the FY2023–FY2025 lists; up 1 since FY2020.
7 $23,632,566
Rank history: #4 in FY2022, #5 in FY2023, #3 in FY2024 and #99 in FY2025; up 1 since FY2020.
8 $23,050,825
Rank history: #12 in FY2022, #15 in FY2023, #4 in FY2024 and not on the FY2025 list; down 4 since FY2020.
9 $17,240,253
Rank history: #6 in FY2022, #28 in FY2023, #22 in FY2024 and not on the FY2025 list; up 4 since FY2020.
10 $13,578,909
Rank history: #59 in FY2022, #9 in FY2023, not on the FY2024 list and #64 in FY2025; new, not ranked in FY2020.
11 $13,571,395
Rank history: #14 in FY2022, #22 in FY2023, #5 in FY2024 and #19 in FY2025; up 5 since FY2020.
12 $13,261,657
Rank history: #18 in FY2022, #62 in FY2023, not on the FY2024 list and #66 in FY2025; down 3 since FY2020.
13 $12,758,157
Rank history: #22 in FY2022, #44 in FY2023, #26 in FY2024 and #24 in FY2025; up 10 since FY2020.
14 $9,885,816
Rank history: not on the FY2022 list, #13 in FY2023 and not on the FY2024–FY2025 lists; new, not ranked in FY2020.
15 $7,952,833
Rank history: #29 in FY2022, #29 in FY2023, #17 in FY2024 and #11 in FY2025; up 19 since FY2020.
16 $6,292,918
Rank history: #35 in FY2022, #46 in FY2023, #52 in FY2024 and #58 in FY2025; up 2 since FY2020.
17 $6,229,693
Rank history: #30 in FY2022 and not on the FY2023–FY2025 lists; up 2 since FY2020.
18 $4,328,786
Rank history: #20 in FY2022, #27 in FY2023, #12 in FY2024 and #9 in FY2025; up 10 since FY2020.
19 $3,905,384
Rank history: #23 in FY2022, #33 in FY2023, #11 in FY2024 and #38 in FY2025; up 43 since FY2020.
20 $3,534,924
Rank history: #21 in FY2022, #32 in FY2023, #27 in FY2024 and #16 in FY2025; up 5 since FY2020.
21 $3,200,000
Rank history: #19 in FY2022 and not on the FY2023–FY2025 lists; new, not ranked in FY2020.
22 $3,124,198
Rank history: #3 in FY2022, #24 in FY2023, #8 in FY2024 and not on the FY2025 list; down 1 since FY2020.
23 $2,255,299
Rank history: #27 in FY2022, #31 in FY2023, #14 in FY2024 and not on the FY2025 list; up 18 since FY2020.
24 $2,000,000
Rank history: not on the FY2022–FY2025 lists; new, not ranked in FY2020.
25 $1,911,905
Rank history: #32 in FY2022, #34 in FY2023, #43 in FY2024 and not on the FY2025 list; up 55 since FY2020.
26 $1,752,354
Rank history: not on the FY2022 list, #4 in FY2023 and not on the FY2024–FY2025 lists; down 15 since FY2020.
27 $1,635,862
Rank history: #40 in FY2022, #82 in FY2023 and not on the FY2024–FY2025 lists; up 15 since FY2020.
28 $1,612,854
Rank history: #26 in FY2022, #25 in FY2023, #16 in FY2024 and not on the FY2025 list; new, not ranked in FY2020.
29 $1,531,456
Rank history: #36 in FY2022, #55 in FY2023 and not on the FY2024–FY2025 lists; up 6 since FY2020.
30 $1,502,748
Rank history: not on the FY2022 list, #54 in FY2023 and not on the FY2024–FY2025 lists; up 81 since FY2020.
31 $1,483,242
Rank history: #41 in FY2022, #40 in FY2023, #19 in FY2024 and #23 in FY2025; up 17 since FY2020.
32 $1,397,100
Rank history: #50 in FY2022, #39 in FY2023, #24 in FY2024 and #20 in FY2025; up 4 since FY2020.
33 $1,386,125
Rank history: #65 in FY2022, #94 in FY2023, #98 in FY2024 and not on the FY2025 list; up 190 since FY2020.
35 $1,208,336
Rank history: #81 in FY2022, #45 in FY2023, #28 in FY2024 and not on the FY2025 list; new, not ranked in FY2020.
36 $1,171,195
Rank history: #45 in FY2022, #58 in FY2023, #20 in FY2024 and not on the FY2025 list; up 13 since FY2020.
37 $1,139,967
Rank history: not on the FY2022–FY2025 lists; new, not ranked in FY2020.
38 $1,050,569
Rank history: #75 in FY2022 and not on the FY2023–FY2025 lists; new, not ranked in FY2020.
39 $1,045,489
Rank history: not on the FY2022–FY2025 lists; down 22 since FY2020.
40 $1,020,068
Rank history: #82 in FY2022 and not on the FY2023–FY2025 lists; up 3 since FY2020.
41 $994,128
Rank history: #31 in FY2022, #37 in FY2023, #73 in FY2024 and not on the FY2025 list; down 4 since FY2020.
42 $949,141
Rank history: #46 in FY2022, #38 in FY2023, #23 in FY2024 and #15 in FY2025; up 17 since FY2020.
43 $854,244
Rank history: #47 in FY2022, #51 in FY2023, #34 in FY2024 and #26 in FY2025; up 50 since FY2020.
44 $834,005
Rank history: #60 in FY2022, #59 in FY2023, #42 in FY2024 and #35 in FY2025; up 1 since FY2020.
45 $832,865
Rank history: #51 in FY2022, #48 in FY2023, #32 in FY2024 and #25 in FY2025; up 11 since FY2020.
46
Ortho-Clinical Diagnostics Singapore PTE. Ltd. Korea Branch 2 awardees, including Ortho-Clinical Diagnostics GMBH
$830,838
Rank history: not on the FY2022 list, #52 in FY2023, #49 in FY2024 and #27 in FY2025; up 75 since FY2020.
47 $752,403
Rank history: #34 in FY2022, #7 in FY2023 and not on the FY2024–FY2025 lists; down 37 since FY2020.
48 $749,000
Rank history: not on the FY2022–FY2025 lists; new, not ranked in FY2020.
49 $749,000
Rank history: not on the FY2022–FY2025 lists; new, not ranked in FY2020.
50 $734,023
Rank history: #77 in FY2022, #81 in FY2023, not on the FY2024 list and #62 in FY2025; up 14 since FY2020.
51
Biodiscovery LLC
$728,680
Rank history: #63 in FY2022 and not on the FY2023–FY2025 lists; up 69 since FY2020.
52 $645,685
Rank history: #54 in FY2022, #47 in FY2023, #37 in FY2024 and #14 in FY2025; down 12 since FY2020.
53 $628,391
Rank history: #56 in FY2022, #63 in FY2023, #90 in FY2024 and not on the FY2025 list; up 10 since FY2020.
54 $615,817
Rank history: #61 in FY2022, #57 in FY2023, #59 in FY2024 and #46 in FY2025; up 27 since FY2020.
55 $612,773
Rank history: not on the FY2022 list, #90 in FY2023 and not on the FY2024–FY2025 lists; up 14 since FY2020.
56 $611,363
Rank history: not on the FY2022–FY2025 lists; up 48 since FY2020.
57 $603,004
Rank history: #68 in FY2022, #68 in FY2023, #53 in FY2024 and #43 in FY2025; new, not ranked in FY2020.
58 $542,108
Rank history: #66 in FY2022, #61 in FY2023 and not on the FY2024–FY2025 lists; up 19 since FY2020.
59 $529,878
Rank history: not on the FY2022–FY2025 lists; new, not ranked in FY2020.
60 $502,834
Rank history: not on the FY2022–FY2023 lists, #46 in FY2024 and #98 in FY2025; down 38 since FY2020.
61
Life Technologies GMBH
$491,671
Rank history: not on the FY2022–FY2025 lists; new, not ranked in FY2020.
62 $478,691
Rank history: not on the FY2022–FY2025 lists; down 47 since FY2020.
63 $476,000
Rank history: not on the FY2022–FY2025 lists; new, not ranked in FY2020.
64 $462,267
Rank history: #88 in FY2022, #76 in FY2023 and not on the FY2024–FY2025 lists; new, not ranked in FY2020.
65 $434,149
Rank history: not on the FY2022–FY2025 lists; down 45 since FY2020.
66
Atos Medical Inc.
$406,700
Rank history: not on the FY2022 list, #73 in FY2023, #36 in FY2024 and not on the FY2025 list; new, not ranked in FY2020.
67 $393,900
Rank history: #58 in FY2022, #60 in FY2023, #40 in FY2024 and not on the FY2025 list; down 14 since FY2020.
68 $383,928
Rank history: not on the FY2022–FY2025 lists; up 32 since FY2020.
69 $377,568
Rank history: #91 in FY2022 and not on the FY2023–FY2025 lists; down 4 since FY2020.
70 $368,640
Rank history: #78 in FY2022, #56 in FY2023, #60 in FY2024 and not on the FY2025 list; new, not ranked in FY2020.
71
Terumo BCT Inc.
$334,784
Rank history: #72 in FY2022, #84 in FY2023 and not on the FY2024–FY2025 lists; down 25 since FY2020.
72 $312,155
Rank history: #87 in FY2022, #80 in FY2023, #69 in FY2024 and #54 in FY2025; up 36 since FY2020.
73 $299,442
Rank history: #97 in FY2022, #86 in FY2023, #65 in FY2024 and #61 in FY2025; new, not ranked in FY2020.
74 $291,710
Rank history: #79 in FY2022, #67 in FY2023, #57 in FY2024 and #51 in FY2025; up 36 since FY2020.
75 $286,996
Rank history: #70 in FY2022, #75 in FY2023, #44 in FY2024 and #37 in FY2025; down 25 since FY2020.
76 $285,721
Rank history: #62 in FY2022, not on the FY2023 list, #41 in FY2024 and not on the FY2025 list; up 3 since FY2020.
77 $269,806
Rank history: not on the FY2022–FY2025 lists; down 39 since FY2020.
78 $256,457
Rank history: #100 in FY2022 and not on the FY2023–FY2025 lists; down 2 since FY2020.
79 $251,750
Rank history: not on the FY2022–FY2023 lists, #84 in FY2024 and not on the FY2025 list; up 127 since FY2020.
80 $244,210
Rank history: not on the FY2022–FY2025 lists; down 74 since FY2020.
81 $237,600
Rank history: not on the FY2022–FY2025 lists; new, not ranked in FY2020.
82 $228,810
Rank history: #94 in FY2022 and not on the FY2023–FY2025 lists; new, not ranked in FY2020.
83 $225,649
Rank history: not on the FY2022–FY2025 lists; down 1 since FY2020.
84 $219,928
Rank history: not on the FY2022–FY2025 lists; up 46 since FY2020.
85 $218,228
Rank history: not on the FY2022–FY2023 lists, #6 in FY2024 and #2 in FY2025; down 59 since FY2020.
86 $209,353
Rank history: not on the FY2022–FY2025 lists; new, not ranked in FY2020.
87 $208,694
Rank history: #67 in FY2022, #65 in FY2023, #56 in FY2024 and #78 in FY2025; down 21 since FY2020.
88 $206,912
Rank history: #95 in FY2022, #69 in FY2023, #83 in FY2024 and not on the FY2025 list; up 71 since FY2020.
89 $205,747
Rank history: not on the FY2022–FY2025 lists; new, not ranked in FY2020.
90 $190,464
Rank history: not on the FY2022–FY2025 lists; up 4 since FY2020.
91 $183,468
Rank history: not on the FY2022–FY2025 lists; up 78 since FY2020.
92 $182,276
Rank history: not on the FY2022–FY2025 lists; new, not ranked in FY2020.
93 $180,622
Rank history: not on the FY2022–FY2023 lists, #80 in FY2024 and #82 in FY2025; up 54 since FY2020.
94 $178,524
Rank history: not on the FY2022 list, #95 in FY2023 and not on the FY2024–FY2025 lists; up 38 since FY2020.
95 $177,830
Rank history: not on the FY2022–FY2025 lists; up 38 since FY2020.
96 $172,435
Rank history: not on the FY2022 list, #77 in FY2023, #82 in FY2024 and #53 in FY2025; up 44 since FY2020.
97 $168,525
Rank history: not on the FY2022–FY2025 lists; up 9 since FY2020.
98 $164,455
Rank history: not on the FY2022–FY2025 lists; new, not ranked in FY2020.
99 $162,168
Rank history: not on the FY2022–FY2025 lists; up 30 since FY2020.
100
Alfresa Holdings Corporation Through Alfresa Corporation
$157,781
Rank history: #57 in FY2022, #100 in FY2023 and not on the FY2024–FY2025 lists; up 82 since FY2020.
Show 75 more

100 of 267 contractors listed here. See the rest on GovTribe.

How this ranking works

  • Source: every contract action FPDS records (as published on SAM.gov) in the period, as GovTribe received it.
  • Amounts are net obligations: what was obligated, less what was deobligated. Shares are of $2.11 billion obligated before deobligations, so they never pass 100%.
  • Parent companies: each action counts under the ultimate parent its award record names, or under the awardee when it names none, so no dollar counts twice. Parents of the same name (Inc., LLC and the like aside) count as one company, since FPDS records a company's parent under more than one UEI over time. GovTribe corrects a few parents and names by hand; see the corrections.
  • Fiscal year 2021 ran Oct 1, 2020 – Sep 30, 2021. The Department of Defense reports its contract actions to FPDS about 90 days late, so a fiscal year is ranked once they're in, in February, and the list doesn't change after.
  • Rank changes compare with FY2020. "New" marks a company outside that period's top 500, and "Returned" one of those that was on an earlier fiscal year's list.
  • Rank lines show each company's rank on every fiscal year's list since FY2021, #1 at the top, on a scale that gives the top of the list more room. A dashed stretch spans years it wasn't on the list. The step from FY2020 takes the color of the rank change beside it.
  • Placeholder recipients FPDS uses when it names no company ("Miscellaneous Foreign Contractors" and the like) aren't ranked.

Quick answers

Who were the top 10 NAICS 325413 contractors in FY2021?

1. Abbott Laboratories ($1.38B), 2. Abbott Rapid DX North America LLC ($158M), 3. Thermo Electron Corporation ($81.5M), 4. Danaher Corporation ($76.1M), 5. Ortho-Clinical Diagnostics, Inc. ($54.3M), 6. Grifols Diagnostic Solutions Inc. ($39M), 7. Roche Holding AG ($23.6M), 8. Compagnie Merieux Alliance ($23.1M), 9. Becton, Dickinson and Co ($17.2M), 10. Orasure Technologies Inc. ($13.6M).

On GovTribe

Research every contractor on this list

  • Every contract, task order and IDV they hold
  • Their subsidiaries, teammates and competitors
  • Open opportunities they're positioned for
  • Alerts when they win new work